On October 2, PHARMARON fell 4.9% in regular trading, trading at HK$30.32/share, with turnover of HK$13.97 million.

Within the Life Sciences Tools & Services sector where PHARMARON belongs, the overall sector showed broad-based weakness. Among individual stocks, WUXI APPTEC down 2.97%, WUXI BIO down 2.77%, GENSCRIPT BIO down 4.32%, INSILICO down 6.24%, WUXI XDC down 3.78%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)